rs3793744

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001776.6(ENTPD1):​c.877G>A​(p.Val293Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00343 in 1,614,134 control chromosomes in the GnomAD database, including 145 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. V293V) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.017 ( 78 hom., cov: 32)
Exomes 𝑓: 0.0020 ( 67 hom. )

Consequence

ENTPD1
NM_001776.6 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -0.254

Publications

9 publications found
Variant links:
Genes affected
ENTPD1 (HGNC:3363): (ectonucleoside triphosphate diphosphohydrolase 1) The protein encoded by this gene is a plasma membrane protein that hydrolyzes extracellular ATP and ADP to AMP. Inhibition of this protein's activity may confer anticancer benefits. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2015]
ENTPD1-AS1 (HGNC:45203): (ENTPD1 antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0022000968).
BP6
Variant 10-95847509-G-A is Benign according to our data. Variant chr10-95847509-G-A is described in ClinVar as Benign. ClinVar VariationId is 703843.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0557 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ENTPD1NM_001776.6 linkc.877G>A p.Val293Ile missense_variant Exon 7 of 10 ENST00000371205.5 NP_001767.3 P49961-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ENTPD1ENST00000371205.5 linkc.877G>A p.Val293Ile missense_variant Exon 7 of 10 1 NM_001776.6 ENSP00000360248.4 P49961-1

Frequencies

GnomAD3 genomes
AF:
0.0170
AC:
2594
AN:
152150
Hom.:
74
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0573
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00628
Gnomad ASJ
AF:
0.000288
Gnomad EAS
AF:
0.0148
Gnomad SAS
AF:
0.000829
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000162
Gnomad OTH
AF:
0.0158
GnomAD2 exomes
AF:
0.00548
AC:
1379
AN:
251430
AF XY:
0.00406
show subpopulations
Gnomad AFR exome
AF:
0.0581
Gnomad AMR exome
AF:
0.00266
Gnomad ASJ exome
AF:
0.000794
Gnomad EAS exome
AF:
0.0158
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000211
Gnomad OTH exome
AF:
0.00212
GnomAD4 exome
AF:
0.00200
AC:
2917
AN:
1461866
Hom.:
67
Cov.:
33
AF XY:
0.00173
AC XY:
1260
AN XY:
727236
show subpopulations
African (AFR)
AF:
0.0566
AC:
1896
AN:
33480
American (AMR)
AF:
0.00291
AC:
130
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.000574
AC:
15
AN:
26132
East Asian (EAS)
AF:
0.0111
AC:
442
AN:
39698
South Asian (SAS)
AF:
0.000162
AC:
14
AN:
86256
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53420
Middle Eastern (MID)
AF:
0.00347
AC:
20
AN:
5768
European-Non Finnish (NFE)
AF:
0.000104
AC:
116
AN:
1111996
Other (OTH)
AF:
0.00470
AC:
284
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
181
363
544
726
907
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
74
148
222
296
370
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0172
AC:
2615
AN:
152268
Hom.:
78
Cov.:
32
AF XY:
0.0168
AC XY:
1251
AN XY:
74444
show subpopulations
African (AFR)
AF:
0.0576
AC:
2392
AN:
41534
American (AMR)
AF:
0.00627
AC:
96
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.000288
AC:
1
AN:
3472
East Asian (EAS)
AF:
0.0149
AC:
77
AN:
5180
South Asian (SAS)
AF:
0.000830
AC:
4
AN:
4820
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10616
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000162
AC:
11
AN:
68028
Other (OTH)
AF:
0.0161
AC:
34
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
122
244
366
488
610
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
30
60
90
120
150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00827
Hom.:
56
Bravo
AF:
0.0192
ESP6500AA
AF:
0.0601
AC:
265
ESP6500EA
AF:
0.000930
AC:
8
ExAC
AF:
0.00631
AC:
766
EpiCase
AF:
0.000218
EpiControl
AF:
0.0000593

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

May 05, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

ENTPD1-related disorder Benign:1
Jan 03, 2020
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Hereditary spastic paraplegia Benign:1
Jan 17, 2022
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hereditary spastic paraplegia 64 Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.075
BayesDel_addAF
Benign
-0.77
T
BayesDel_noAF
Benign
-0.84
CADD
Benign
0.029
DANN
Benign
0.60
DEOGEN2
Benign
0.080
.;.;.;T
Eigen
Benign
-1.4
Eigen_PC
Benign
-1.4
FATHMM_MKL
Benign
0.061
N
LIST_S2
Benign
0.55
T;T;T;T
MetaRNN
Benign
0.0022
T;T;T;T
MetaSVM
Benign
-0.96
T
MutationAssessor
Benign
0.43
.;.;.;N
PhyloP100
-0.25
PrimateAI
Benign
0.22
T
PROVEAN
Benign
0.070
N;N;N;N
REVEL
Benign
0.019
Sift
Benign
0.50
T;T;T;T
Sift4G
Benign
0.52
T;T;T;T
Polyphen
0.0040
B;.;.;B
Vest4
0.030
MVP
0.082
MPC
0.13
ClinPred
0.00030
T
GERP RS
-5.7
Varity_R
0.019
gMVP
0.41
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3793744; hg19: chr10-97607266; COSMIC: COSV64601433; COSMIC: COSV64601433; API